MicroRNAs
(miRNAs) are a family of small noncoding RNAs that regulate
gene expression. Due to their important activity in the fine-tuning
of protein translation, abnormal expression of miRNAs has been linked
to many human diseases, making the targeting of miRNAs attractive
as a novel therapeutic strategy. Accordingly, researchers have been
heavily engaged in the discovery of small molecule modulators of miRNAs.
With an interest in the identification of new chemical space for targeting
miRNAs, we developed a high-throughput screening (HTS) technology,
catalytic enzyme-linked click chemistry assay (cat-ELCCA), aimed at
the discovery of small molecule ligands for pre-miR-21, a miRNA that
is frequently overexpressed in human cancers. From our HTS campaign,
we found that natural products, a source of many impactful human medicines,
may be a promising source of potential pre-miR-21-selective maturation
inhibitors. Herein we describe our first efforts in natural product
inhibitor discovery leading to the identification of a depsipeptide
class of natural products as RNA-binding inhibitors of Dicer-mediated
miRNA processing.